Clinical Trial Update: Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects [Phase 1, Phase 2]

View source ↗

Summary

Intralytix reports suspension of the Phase 1/Phase 2 clinical trial evaluating the oral phage cocktail VRELysin for vancomycin-resistant Enterococcus colonizati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vancomycin-resistant Enterococcus Colonization

Drugs mentioned

• VRELysin

Snippet

Sponsor: Intralytix, Inc. | Conditions: Vancomycin-Resistant Enterococcal Colonization | Phase 1, Phase 2 | Status: SUSPENDED